Pfizer announces Phase 3 clinical trial for vaccine against Respiratory Syncytial Virus (RSV)
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg
Subscribe To Our Newsletter & Stay Updated